Workflow
Earnings Estimate Revisions
icon
Search documents
Bilibili (BILI) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZACKS· 2025-07-01 17:01
Bilibili (BILI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power ...
Coca-Cola (KO) Upgraded to Buy: Here's Why
ZACKS· 2025-07-01 17:01
Coca-Cola (KO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing earnin ...
Advanced Energy (AEIS) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-07-01 17:01
Investors might want to bet on Advanced Energy Industries (AEIS) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the s ...
What Makes SBA Communications (SBAC) a New Buy Stock
ZACKS· 2025-07-01 17:01
SBA Communications (SBAC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a ...
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock?
ZACKS· 2025-07-01 15:31
Immunome, Inc. (IMNM) shares rallied 6% in the last trading session to close at $9.3. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.1% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism regarding the company’s efforts to develop its lead pipeline candidate, varegacestat, which is currently in late-stage clinical studies for the treatment of desmoid tumors. I ...
Wall Street Analysts Predict a 38.88% Upside in Darling (DAR): Here's What You Should Know
ZACKS· 2025-07-01 14:56
Core Viewpoint - Darling Ingredients (DAR) has shown a significant price increase of 23.2% over the past four weeks, with a mean price target of $52.69 indicating a potential upside of 38.9% from the current price of $37.94 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $18.88, suggesting variability in analyst predictions. The lowest estimate is $34.00 (10.4% decline), while the highest is $110.00 (189.9% increase) [2] - Analysts' price targets can often mislead investors, as empirical research indicates that these targets rarely reflect actual stock price movements [7][10] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about DAR's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.4%, with one estimate moving higher and no negative revisions [12] - DAR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a solid potential upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of DAR's potential gains, the implied direction of price movement appears to be a useful guide for investors [14]
Radius Recycling (RDUS) Reports Q3 Loss, Beats Revenue Estimates
ZACKS· 2025-07-01 14:36
Radius Recycling (RDUS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to a loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +55.17%. A quarter ago, it was expected that this recycler of ferrous and nonferrous scrap metal would post a loss of $1.08 per share when it actually produced a loss of $0.99, delivering a surprise of +8.33%. Over the ...
5 Must-Watch Stocks Favored by Brokers as 2H25 Begins
ZACKS· 2025-07-01 14:01
Key Takeaways Brokers favor CBRL, BGSF, ARCB, CAH and AN as 2H25 begins with positive estimate revisions and value metrics. A screening strategy using broker ratings, earnings estimate revisions, and valuation picked these stocks. A host of positives, led by easing of trade tensions and cooling inflation, raise optimism about 2H25.The first half of 2025 was characterized by heightened volatility and uncertainty. President Trump’s sweeping tariffs rattled markets before a partial pause, and the faster-than ...
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
ZACKS· 2025-07-01 14:01
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this vaccine maker have returned -10.9%, compared to the Zacks S&P 500 composite's +5.2% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax falls in, has gained 0.9%. The key question now is: What could be the stock's future di ...
Strength Seen in First United (FUNC): Can Its 6.1% Jump Turn into More Strength?
ZACKS· 2025-07-01 13:06
First United Corporation (FUNC) shares ended the last trading session 6.1% higher at $31.01. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.8% loss over the past four weeks.First United became a part of the Russell 2500 Index, a mid-cap benchmark, effective yesterday. The bank’s inclusion signals its market cap growth and compliance with index criteria. This move boosted short-term liquidity and trading volume a ...